ASCO GUIDELINES Bundle

Fertility Preservation in Cancer Patients

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475461

Contents of this Issue

Navigation

Page 4 of 5

Role of Health Care Providers Recommendation 4.1 ➤ All oncologic health care providers should be prepared to discuss infertility as a potential risk of therapy. This discussion should take place as soon as possible once a cancer diagnosis is made and can occur simultaneously with staging and the formulation of a treatment plan. There are benefits for patients in discussing fertility information with providers at every step of the cancer journey. Recommendation 4.2 ➤ Encourage patients to participate in registries and clinical studies, as available, to define further the safety and efficacy of these interventions and strategies. Recommendation 4.3 ➤ Refer patients who express an interest in fertility, as well as those who are ambivalent or uncertain, to reproductive specialists as soon as possible. Recommendation 4.4 ➤ Refer patients to psychosocial providers when they are distressed about potential infertility. Special Considerations: Children Recommendation 5.1 ➤ Suggest established methods of fertility preservation (e.g., semen or oocyte cryopreservation) for postpubertal children, with patient assent and parent or guardian consent. For prepubertal children, the only fertility preservation options are ovarian and testicular cryopreservation, which are investigational.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Fertility Preservation in Cancer Patients